Section Arrow
Quote
DHGR.NYSE-M
- Devonian Health Group Inc
Quotes are at least 15-min delayed:2026/09/21 17:21 EDT
After Hours
Last
 --
-- (--)
Bid
--
Ask
--
High -- 
Low -- 
Volume -- 
Regular Hours (Closed)
Last
 --
-- (--)
Day High 
-- 
Prev. Close
-- 
1-M High
-- 
Volume 
-- 
Bid
--
Ask
--
Day Low
-- 
Open
-- 
1-M Low
-- 
Market Cap 
-- 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA -- 
20-SMA -- 
50-SMA -- 
52-W High -- 
52-W Low -- 
Exchange NYSE-M 
Valuation Estimation
EPS (Current/Estimated)
-2.25/--
Enterprise Value
--
Balance Sheet
Book Value Per Share
1.79
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
--
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
RXRXRecursion Pharmaceuticals3.97+0.14+3.66%-- 
After Hours 3.96 -0.01 -0.25%
MRNAModerna172.94+18.9+12.27%-- 
After Hours 172.56 -0.38 -0.22%
SLXNSilexion Therapeutics Corp.0.5441+0.1086+24.94%-- 
After Hours 0.5421 -0.002 -0.37%
CELZCreative Medical Technology Holdings1.005+0.0391+4.05%-- 
After Hours 0.97 -0.035 -3.48%
PDSBPDS Biotechnology Corp0.8419+0.0364+4.52%-- 
After Hours 0.83 -0.0119 -1.41%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Devonian Health Group Inc is operating in the pharmaceutical sector. It is engaged in the development and distribution of botanical drugs. The group is also involved in the development of value-added products for dermo-cosmetics. It has established a research effort focused on the anticipation of new solutions in the medical sector as well as in the cosmetic sector. The company's technology platform, The Supra Molecular Complex Extraction and Stabilization Technology provides a process of extraction, purification, stabilization, and conditioning of molecular complexes, as active botanical ingredients, from plants and algae. Its product portfolio includes pharmaceuticals like Thykamine, Pantoprazole, and Cleo-35; and cosmeceutical products like R-Spinasome and Purgenesis.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.